Morning Alert : Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK), Campus Crest Communities, Inc. (NYSE:CCG), Worthington Industries, Inc. (NYSE:WOR), Facebook Inc (NASDAQ:FB), Google Inc (NASDAQ:GOOG)

Merrimack Pharmaceuticals (NASDAQ:MACK) SVP Edward J. Stewart unloaded 3,000 shares of the company’s stock on the open market in a transaction that occurred on Thursday, October 23rd. The shares were sold at an average price of $9.05, for a total transaction of $27,150.00. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) shares moved up 2.07% in last trading session and ended the day at $9.35. MACK return on assets … Continue reading Morning Alert : Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK), Campus Crest Communities, Inc. (NYSE:CCG), Worthington Industries, Inc. (NYSE:WOR), Facebook Inc (NASDAQ:FB), Google Inc (NASDAQ:GOOG)

Worth Watching Stocks : SunPower Corporation (NASDAQ:SPWR), Citrix Systems, Inc. (NASDAQ:CTXS), First Niagara Financial Group Inc. (NASDAQ:FNFG), Worthington Industries (NYSE:WOR), Neonode (NASDAQ:NEON)

JPMorgan Chase & Co. upgraded shares of SunPower (NASDAQ:SPWR) to an overweight rating in a research note issued to investors on Friday. SunPower Corporation (NASDAQ:SPWR) belongs to Technology sector. Its net profit margin is 8.40% and weekly performance is 7.96%. On last trading day company shares ended up $31.21. SunPower Corporation (NASDAQ:SPWR) distance from 50-day simple moving average (SMA50) is -10.79%. Shares of Citrix Systems, … Continue reading Worth Watching Stocks : SunPower Corporation (NASDAQ:SPWR), Citrix Systems, Inc. (NASDAQ:CTXS), First Niagara Financial Group Inc. (NASDAQ:FNFG), Worthington Industries (NYSE:WOR), Neonode (NASDAQ:NEON)

On Dec 12, Oncothyreon Inc. announced that Array BioPharma, Inc. (NASDAQ:ARRY) has granted Oncothyreon an exclusive license to develop, manufacture and commercialize ONT-380 (ARRY-380), an orally active, reversible and selective small molecule HER2 inhibitor. The license agreement replaces the prior Development and Collaboration Agreement under which Oncothyreon and Array were jointly developing ONT-380. Array BioPharma, Inc. (NASDAQ:ARRY) belongs to Healthcare sector. Its weekly performance is … Continue reading Investors Should Watch: Array BioPharma, Inc. (NASDAQ:ARRY), Comcast Corporation (NASDAQ:CMCSA), Tech Data Corp. (NASDAQ:TECD), Worthington Industries, Inc. (NYSE:WOR), LDR Holding Corporation (NASDAQ:LDRH)